EvoEndo

EvoEndo is a developer of a medical system designed to offer unsedated endoscopy procedures for pediatric and adult patients
2017
18
Colorado, United States

Innovation

Industry Problem

Endoscopy procedures uses general anesthesia, or conscious sedation

R&D Focus

Unsedated endoscopy procedures

Innovative Solution

EvoEndo Model Gastroscope is designed to visualize the upper digestive tract in adults and children, primarily for the observation, diagnosis, and endoscopic treatment of the esophagus, stomach, and duodenum

Solution Effectiveness

EvoEndo Scope is a sterile, single-use technology that does not require repairs or reprocessing

Investment Funding

Last Funding Stage

Debt

Total Funding Amount

$30.9M

Last Funding Amount

$2.25M

Startup Stage

Early-Stage

Lead Investors

American Gastroenterological Association, AdvaMed Accel, Medmarc Casualty Insurance Company, MedTech Innovator, AllerFund Ventures

People

Founders

CEO

Products

Product

EvoEndo® System

Demo Product or Complete Product?

Complete Product, April 2024

Future Plan

Market Expansion

EvoEndo’s system is gradually being rolled out to healthcare sites across the US, with the rollout at Duke Health following a launch in a Texas paediatric hospital in April 2024

Awards and Recognitions

Awards

2022 MedTech Innovator Execution Award

Media Apperance

Medical Product Outsourcing, Medical Device Network

Certifications

510(k) clearance from the U.S. Food and Drug Administration

M&A and Collabs

Collab

EvoEndo and Micro-Tech Endoscopy Announce Partnership for Single-Use Unsedated Endoscopy System